These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 2382997)
41. [The CA 19-9, CA 125, CA 72-4 and CA 50 tumor markers in neoplastic disease: results of a 3-year experience]. Fratta M; Cioffi M; De Lucia D; Bresciani F J Nucl Med Allied Sci; 1990; 34(4 Suppl):285-8. PubMed ID: 2092135 [No Abstract] [Full Text] [Related]
43. [Basic and clinical studies on ELSA CA 72-4 kit for measurement of serum CA 72-4 concentrations: usefulness in patients with gastrointestinal cancer]. Nakai T; Endo K; Nakajima K; Hattori N; Hosono M; Saga T; Watanabe Y; Sakahara H; Konishi J; Tobe T Kaku Igaku; 1990 May; 27(5):505-11. PubMed ID: 2395235 [No Abstract] [Full Text] [Related]
44. [Usefulness of a CA 130 kit based on IRMA (immunoradiometric assay)]. Fujii T; Kimura Y; Ata M; Miyagawa N; Iio A; Hamamoto K Kaku Igaku; 1988 Nov; 25(11):1283-90. PubMed ID: 3221519 [No Abstract] [Full Text] [Related]
46. Development of radioimmunoassays on microplate: application for CA-GI and CA-Br tumor markers. Wu JT; Erali M J Clin Lab Anal; 1993; 7(6):341-7. PubMed ID: 7506304 [TBL] [Abstract][Full Text] [Related]
47. How close are we to finding noninvasive markers for upper GI tract cancer? Skipworth RJ; Husi H; Ross JA Future Oncol; 2011 Oct; 7(10):1121-4. PubMed ID: 21992724 [No Abstract] [Full Text] [Related]
48. [Value of gastrinemia in digestive pathology]. Varas Lorenzo MJ; Luque González MT; Nieto Martínez N Rev Clin Esp; 1979 May; 153(4):293-8. PubMed ID: 493584 [No Abstract] [Full Text] [Related]
49. Circulating blood group related carbohydrate antigens as tumour markers. Orntoft TF; Bech E Glycoconj J; 1995 Jun; 12(3):200-5. PubMed ID: 7496132 [TBL] [Abstract][Full Text] [Related]
50. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer? Eskelinen M; Pasanen P; Janatuinen E; Pettersson N; Linnane A; Alhava E Anticancer Res; 1995; 15(5B):2351-6. PubMed ID: 8572651 [TBL] [Abstract][Full Text] [Related]
51. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700. van Dalen A; Kessler AC Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058 [TBL] [Abstract][Full Text] [Related]
52. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study. Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729 [TBL] [Abstract][Full Text] [Related]
53. [CA-125 in non-ovarian benign and malignant pathology: study on 380 patients]. Marechal F; Berthiot G; Kritly T; Legrand MG; Deltour G; Cattan A Bull Cancer; 1989; 76(7):697-706. PubMed ID: 2819261 [TBL] [Abstract][Full Text] [Related]
54. CA-50 and CA-19.9 as tumour markers: which is preferable? Maréchal F; Berthiot G; Legrand MG; Larbre H; Cattan A; Deltour G Anticancer Res; 1990; 10(4):977-82. PubMed ID: 2382997 [TBL] [Abstract][Full Text] [Related]